Equities
  • Price (USD)72.29
  • Today's Change-0.47 / -0.65%
  • Shares traded168.57k
  • 1 Year change-15.02%
  • Beta0.8612
Data delayed at least 15 minutes, as of Apr 24 2024 16:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Henry Schein, Inc. is a solutions company for health care professionals. The Company's business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work to provide quality care. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. The Company's Health Care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products, diagnostic tests, infection-control products, personal protective equipment products (PPE) and vitamins. Its Technology and Value-added services segment provide software, technology and other value-added services to healthcare practitioners. The Company also operates as a supplier of homecare medical products delivered directly to patients in their homes.

  • Revenue in USD (TTM)12.34bn
  • Net income in USD416.00m
  • Incorporated1992
  • Employees25.00k
  • Location
    Henry Schein Inc135 Duryea RdMELVILLE 11747United StatesUSA
  • Phone+1 (631) 843-5500
  • Fax+1 (302) 636-5454
  • Websitehttps://www.henryschein.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HSIC:NSQ since
announced
Transaction
value
TriMed IncAnnounced07 Dec 202307 Dec 2023Announced2.36%--
Shield HealthCare IncDeal completed03 Aug 202303 Aug 2023Deal completed-9.31%--
Large Practice Sales LLCDeal completed02 Aug 202302 Aug 2023Deal completed-8.28%--
Regional Health Care Group Pty LtdDeal completed07 May 202307 May 2023Deal completed-9.35%--
SIN Sistema de Implante Nacional SAAnnounced04 May 202304 May 2023Announced-9.65%--
Data delayed at least 15 minutes, as of Apr 24 2024 16:28 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Glaukos Corp314.71m-134.66m5.05bn907.00--10.75--16.05-2.78-2.786.509.400.3241.898.29346,980.20-13.86-8.73-14.99-9.3575.9974.77-42.79-28.694.78-27.680.4335--11.2611.66-35.75--14.44--
Novanta Inc881.66m72.88m5.72bn2.90k78.798.4847.876.492.022.0224.4718.800.71473.046.36304,021.405.915.466.746.3445.3643.248.277.711.914.830.34770.002.417.49-1.588.214.19--
DENTSPLY SIRONA Inc3.97bn-132.00m6.41bn15.00k--1.9430.371.62-0.6217-0.621718.6715.890.52823.005.98264,333.30-1.76-1.14-2.13-1.3252.7153.65-3.33-2.510.94673.630.3914--1.10-0.107186.11---4.549.86
Globus Medical Inc1.57bn122.87m6.94bn5.00k44.001.7525.854.431.171.1713.7229.320.4380.95574.38313,695.203.436.903.727.4565.0571.737.8314.052.72--0.09470.0053.3417.08-35.39-4.725.57--
Inspire Medical Systems Inc624.80m-21.15m7.09bn1.01k--12.08--11.34-0.7298-0.729821.3219.371.014.228.27618,001.00-3.41-11.27-3.84-12.6084.5484.47-3.39-13.577.17--0.00--53.1965.3252.87--148.37--
Masimo Corp2.05bn81.50m7.25bn3.80k90.885.3040.333.541.511.5137.8425.850.65522.005.04538,973.702.618.653.2210.3149.0057.303.9812.031.223.430.3990.000.604219.00-43.21-15.9631.06--
MSA Safety Inc1.79bn58.52m7.47bn5.10k132.697.7662.624.181.431.4345.2124.590.78632.976.04350,518.802.585.083.036.0047.6745.213.287.021.486.070.383665.9117.005.65-67.41-13.664.72-1.10
Penumbra Inc1.06bn90.95m7.96bn4.20k88.796.7567.357.522.322.3227.0030.480.72321.045.23252,029.006.212.326.912.6164.4963.908.593.173.49--0.02150.0024.9518.934,643.1668.609.64--
Stevanato Group SpA1.16bn155.81m8.22bn5.64k46.325.9534.267.080.58770.58774.384.580.58183.142.75206,072.107.81--10.81--32.28--13.42--1.0619.740.2593--10.34--1.95------
Henry Schein, Inc.12.34bn416.00m9.35bn25.00k23.092.5713.950.75763.153.1593.6728.281.294.497.47493,560.004.406.097.3110.4431.2930.043.424.400.996310.630.31330.00-2.445.55-22.68-0.145621.27--
Teleflex Inc2.97bn357.57m9.94bn14.50k27.932.2416.583.347.567.5362.8894.410.41142.206.98205,137.204.955.865.396.4255.3755.0412.0214.621.297.780.290115.846.573.97-1.4712.732.510.00
Insulet Corp1.70bn206.30m11.71bn3.00k59.3615.9641.976.902.822.8222.7810.480.70141.436.00565,700.008.532.7110.263.1468.3565.8112.164.282.6240.740.6590.0030.0224.664,384.78128.77-7.63--
Shockwave Medical Inc730.23m147.28m12.32bn1.47k85.1418.1778.1716.883.863.8619.1318.080.661.047.86497,431.9013.3110.2914.4011.3986.9484.6920.1715.1410.7319.700.52260.0049.11126.45-31.81--72.88--
Data as of Apr 24 2024. Currency figures normalised to Henry Schein Inc's reporting currency: US Dollar USD

Institutional shareholders

48.22%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 202314.62m11.38%
Generation Investment Management LLPas of 31 Dec 202311.97m9.31%
BlackRock Fund Advisorsas of 31 Dec 20236.62m5.15%
SSgA Funds Management, Inc.as of 31 Dec 20236.51m5.06%
American Century Investment Management, Inc.as of 31 Dec 20235.51m4.29%
JPMorgan Investment Management, Inc.as of 31 Dec 20234.44m3.46%
Invesco Advisers, Inc.as of 31 Dec 20233.84m2.99%
Geode Capital Management LLCas of 31 Dec 20233.07m2.39%
Swedbank Robur Fonder ABas of 29 Feb 20242.76m2.15%
Boston Partners Global Investors, Inc.as of 31 Dec 20232.64m2.05%
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.